References
- FeestTGRajamaheshJByrneCTrends in adult renal replacement therapy in the UK: 1982–2002QJM2005981212815625350
- LisowskaATycińskaAKnappMThe incidence and prognostic significance of cardiac arrhythmias and conduction abnormalities in patients with acute coronary syndromes and renal dysfunctionKardiol Pol20116912:12421247 Polish22219098
- RileyABManningWJAtrial fibrillation: an epidemic in the elderlyExpert Rev Cardiovasc Ther2011981081109021878052
- NabauerMGerthALimbourgTThe Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial managementEuropace200911442343419153087
- FurbergCDPsatyBMManolioTAPrevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)Am J Cardiol19947432362418037127
- HorioTIwashimaYKamideKChronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patientsJ Hypertens20102881738174420485194
- GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
- WolfPAAbbottRDKannelWBAtrial fibrillation as an independent risk factor for stroke: the Framingham studyStroke19912289839881866765
- PicciniJPWallaceTWPatelMRBeckerRCStroke prevention in atrial fibrillationCardiovasc Drugs Ther201125656157021927837
- GageBFWatermanADShannonWValidation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillationJAMA2001285222864287011401607
- NakagawaKHiraiTTakashimaSChronic kidney disease and CHADS2 score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillationAm J Cardiol2011107691291621247518
- SandhuRKKurthTConenDRelation of renal function to risk for incident atrial fibrillation in WomenAm J Cardiol2012109453854222100025
- HartRGPearceLAAsingerRWWarfarin in atrial fibrillation patients with moderate chronic kidney diseaseClin J Am Soc Nephrol20116112599260421903982
- [No authors listed] Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsArch Intern Med199415413144914578018000
- TulnerLRVan CampenJPKuperIMReasons for under treatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive studyDrugs Aging2010271395020030431
- BrodskySVNadasdyTRovinBHWarfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rateKidney Int201180218118921389969
- LeveyASCoreshJBalkENational Kidney FoundationNational Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAnn Intern Med2003139213714712859163
- von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE InitiativeThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesPLoS Med2007410e29617941714
- CammAJKirchhofPLipGYEuropean Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Guidelines for the management of atrial fibrillationEur Heart J201031192369242920802247
- EzekowitzMDLevineJAPreventing stroke in patients with atrial fibrillationJAMA1999281191830183510340371
- KameiKNakanishiKItoSLong-term results of a randomized controlled trial in childhood IgA nephropathyClin J Am Soc Nephrol2011661301130721493743
- YanagitaMThe role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiologyCurr Opin Nephrol Hypertens200413446547015199298
- NagaiKMatsubaraTMimaAGas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathyKidney Int200568255256116014032
- YanagitaMIshiiKOzakiHMechanism of inhibitory effect of warfarin on mesangial cell proliferationJ Am Soc Nephrol199910122503250910589688
- MatésJMPérez-GómezCNúñez de CastroIGlutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/deathInt J Biochem Cell Biol200234543945811906817
- OzcanAWareKCalomeniE5/6 Nephrectomy as a validated rat model mimicking human warfarin-related nephropathyAm J Nephrol201235435636422473220
- ZebboudjAFShinVBostromKMatrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cellsJ Cell Biochem200390475676514587031
- ProudfootDSkepperJNHegyiLApoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodiesCirc Res200087111055106211090552
- BrodskySVSatoskarAChenJAcute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 casesAm J Kidney Dis20095461121112619577348
- MantJHobbsFDFletcherKWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trialLancet2007370958649350317693178
- AliABaileyCAbdelhafizAHStroke prevention with oral anticoagulation in older people with atrial fibrillation – a pragmatic approachAging Dis20123433935123185715